Kaleido Biosciences (KLDO) Competitors $0.0001 -0.04 (-99.75%) As of 09:40 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock KLDO vs. DMN, ZPTA, ELYS, PRST, GROM, KBNT, ALFIW, APCXW, ARBEW, and AOGOWShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Grafiti (DMN), Zapata Computing (ZPTA), Elys BMG Group (ELYS), Presto Automation (PRST), Grom Social Enterprises (GROM), Kubient (KBNT), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), and Arogo Capital Acquisition (AOGOW). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. Grafiti Zapata Computing Elys BMG Group Presto Automation Grom Social Enterprises Kubient Alfi AppTech Payments Arbe Robotics Arogo Capital Acquisition Kaleido Biosciences (NASDAQ:KLDO) and Grafiti (NASDAQ:DMN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, community ranking, analyst recommendations and risk. Does the MarketBeat Community favor KLDO or DMN? Kaleido Biosciences received 54 more outperform votes than Grafiti when rated by MarketBeat users. CompanyUnderperformOutperformKaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% GrafitiN/AN/A Do insiders & institutionals hold more shares of KLDO or DMN? 81.6% of Kaleido Biosciences shares are owned by institutional investors. Comparatively, 11.7% of Grafiti shares are owned by institutional investors. 9.0% of Kaleido Biosciences shares are owned by insiders. Comparatively, 0.3% of Grafiti shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to KLDO or DMN? In the previous week, Grafiti had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for Grafiti and 0 mentions for Kaleido Biosciences. Kaleido Biosciences' average media sentiment score of 0.00 equaled Grafiti'saverage media sentiment score. Company Overall Sentiment Kaleido Biosciences Neutral Grafiti Neutral Is KLDO or DMN more profitable? Kaleido Biosciences has a net margin of 0.00% compared to Grafiti's net margin of -874.43%. Kaleido Biosciences' return on equity of 0.00% beat Grafiti's return on equity.Company Net Margins Return on Equity Return on Assets Kaleido BiosciencesN/A N/A N/A Grafiti -874.43%-1,561.96%-160.38% Which has more risk & volatility, KLDO or DMN? Kaleido Biosciences has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Comparatively, Grafiti has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500. Which has stronger valuation & earnings, KLDO or DMN? Grafiti has lower revenue, but higher earnings than Kaleido Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKaleido Biosciences$1.10M0.00-$95.48M-$2.240.00Grafiti$386.09K0.18-$45.95MN/AN/A SummaryKaleido Biosciences beats Grafiti on 7 of the 11 factors compared between the two stocks. Remove Ads Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$4,000.00$115.89M$5.54B$7.49BDividend YieldN/A3.69%5.35%4.04%P/E Ratio0.003.2023.2518.07Price / Sales0.003,992.08361.2686.80Price / CashN/A13.0138.1634.64Price / BookN/A34.086.493.99Net Income-$95.48M-$87.82M$3.21B$247.18M7 Day PerformanceN/A-3.94%-6.42%-6.42%1 Month PerformanceN/A56.20%-0.68%-7.44%1 Year PerformanceN/A82.41%6.05%-4.31% Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido BiosciencesN/A$0.00-99.8%N/AN/A$4,000.00$1.10M0.0080DMNGrafitiN/A$0.01-59.8%N/AN/A$64,000.00$386,085.000.00N/ANews CoverageGap DownHigh Trading VolumeZPTAZapata Computing1.5543 of 5 stars$0.00-16.7%$1.63+324,900.0%N/A$19,000.00$5.68M0.0050Gap DownELYSElys BMG GroupN/A$0.00flatN/A-99.3%$16,000.00$43.86M0.0090Options VolumePRSTPresto AutomationN/A$0.00flatN/A-99.9%$10,000.00$19.05M0.004GROMGrom Social EnterprisesN/A$0.00flatN/A-99.9%$8,000.00$3.72M0.00450KBNTKubientN/A$0.00flatN/AN/A$1,000.00$1.17M0.0040ALFIWAlfiN/AN/AN/AN/A$0.00$200,684.000.0040APCXWAppTech PaymentsN/A$0.18-6.6%N/A-45.7%$0.00$365,000.000.0020News CoverageGap UpARBEWArbe RoboticsN/A$0.21-10.4%N/A+16.4%$0.00$768,000.000.00120Short Interest ↑News CoveragePositive NewsAOGOWArogo Capital AcquisitionN/A$0.03flatN/AN/A$0.00N/A0.00N/AGap Down Remove Ads Related Companies and Tools Related Companies Grafiti Competitors Zapata Computing Competitors Elys BMG Group Competitors Presto Automation Competitors Grom Social Enterprises Competitors Kubient Competitors Alfi Competitors AppTech Payments Competitors Arbe Robotics Competitors Arogo Capital Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLDO) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
